Evidence supporting the use of: Bacopa
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bacopa monnieri, also known as Brahmi, has a long history of use in traditional Ayurvedic medicine as a cognitive enhancer. In recent decades, its potential for supporting cognitive function, including in dementia, has been investigated scientifically. Preclinical studies have demonstrated antioxidant, neuroprotective, and anti-inflammatory effects of Bacopa extracts, suggesting mechanisms that could theoretically benefit neurodegenerative conditions such as Alzheimer's disease. Some small-scale randomized controlled trials in humans have shown modest improvements in cognitive performance, memory, and attention in elderly subjects and individuals with mild cognitive impairment. However, most of these trials are short in duration, involve small sample sizes, and use varying Bacopa preparations, making it difficult to generalize results. Systematic reviews and meta-analyses conclude that while Bacopa may offer mild cognitive benefits, the evidence is not strong or consistent enough to recommend it as a treatment for dementia. There is insufficient data to determine its efficacy in diagnosed dementia patients, as most studies focus on healthy individuals or those with mild cognitive issues. More large, high-quality clinical trials are needed to clarify Bacopa’s role in dementia management. In summary, while there is some scientific basis for Bacopa’s cognitive effects, the evidence supporting its use specifically for dementia is limited and not definitive.

More about Bacopa
More about Dementia

Products containing Bacopa

We currently have no products on Vitabase that contain this ingredient.